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INTRODUCTION 
 
Cognitive function declines with increasing age. This 
universal phenomenon affects the majority of our 
elders. Impaired cognitive function represents a major 
obstacle for healthy, functional, productive and 
successful aging. With rapidly-aging populations, 
effective interventions are critical for maintaining good 
cognitive function and preventing age-related cognitive 
decline. Candidates for interventions require careful 
evaluation in randomized controlled trials (RCT) [1].   
 
There is increasing worldwide attention to the 
preventive role of lifestyle and behavioral modifications 
that could reduce the risk for cognitive decline. 
Encouraging results are now emerging from a large trial 
in Finland on the efficacy of a multi-domain 
intervention program [2] in improving cognitive 
function. In contrast, two large preventative trials [3, 4] 
did not show hypothesized benefits on cognitive 
outcomes. Although interest in multi-domain 
interventions is currently high, we believe that single 
interventions also offer the potential to improve 
cognitive health for aging populations. Choral singing is 
a novel and promising candidate that has not yet been 
assessed by a well-designed RCT.  
 
People engaging in lifelong music-making have been 
found to have better cognitive outcomes later in life. A 
cross-sectional study showed that older adults who sang 
or played a musical instrument had higher crystallized 
intelligence, higher processing speeds, better letter 
fluency and better learning ability [5]. Both amateur and 
professional singers and musicians have brain features 
younger than their chronological age, suggesting that 
music-making has an age-decelerating effect [6]. 
Singing may therefore be an engaging and effective way 
to prevent age-related cognitive decline.  
 
Singing programs have been found to improve 
cognition and psychological well-being in individuals 
with dementia [7]. A small pilot study found improved 
psychomotor processing speed and reduced neuro-
psychiatric symptoms of dementia after 6 months of 
weekly singing sessions [8]. An RCT involving 89 
dementia patient-caregiver dyads demonstrated that 10 
weeks of singing significantly improved mood, 
orientation, and remote episodic memory, and to a 
lesser extent, attention, executive function and general 
cognition [9]. Furthermore, choral singing interventions 
for non-demented elderly have demonstrable 
psychological benefits, including improved morale, 
decreased loneliness, improved mental health-related 
quality of life (QOL), and reduced levels of anxiety and 
depression compared to controls [10]. Choral singers 
also report higher physical health-related QOL than 
matched controls [11]. Older adults in a choral singing 
intervention not only had higher self-ratings of health, 
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We conducted a randomized controlled trial to examine choral singing’s effect on cognitive decline in aging. 
Older Singaporeans who were at high risk of future dementia were recruited: 47 were assigned to choral 
singing intervention (CSI) and 46 were assigned to health education program (HEP). Participants attended 
weekly one-hour choral singing or weekly one-hour health education for two years. Change in cognitive 
function was measured by a composite cognitive test score (CCTS) derived from raw scores of 
neuropsychological tests; biomarkers included brain magnetic resonance imaging, oxidative damage and 
immunosenescence. The average age of the participants were 70 years and 73/93 (78.5%) were female. The 
change of CCTS from baseline to 24 months was 0.05 among participants in the CSI group and -0.1 among 
participants in the HEP group. The between-group difference (0.15, p=0.042) became smaller (0.12, p=0.09) 
after adjusting for baseline CCTS. No between-group differences on biomarkers were observed. Our data 
support the role of choral singing in improving cognitive health in aging. The beneficial effect is at least 
comparable than that of health education in preventing cognitive decline in a community of elderly people. 
Biological mechanisms underlying the observed efficacy should be further studied. 
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but also better objective health outcomes such as fewer 
visits to seek medical advice and treatment [12]. Choral 
singing‟s cognitive benefits for non-demented older 
adults have not yet been studied, though the findings 
from other singing interventions are promising. An RCT 
found that a music intervention involving rhythmic 
exercises and improvisational singing improved 
cognition and executive function in healthy older adults 
[13] and a small pilot study found that 12 weeks of 
group singing improved memory and verbal fluency, as 
well as lung function [14].  
 
In this RCT, we hypothesized that choral singing would 
improve cognitive health and/or reduce cognitive decline 
in elderly with high risk of dementia. Additionally, choral 
singing would be more effective than health education 
program (the control arm) at improving cognitive health 
and/or reducing cognitive decline in elderly with high 
risk of dementia. Lastly, we hypothesized that the 
improvement of cognitive health (measured by composite 
cognitive test scores) will be accompanied by change in 
biological measures of brain ageing derived from 
magnetic resonance imaging, immune markers of ageing 
and markers of oxidative damage. 
 
Therefore, we compared the effect of a two-year, 
weekly choral singing intervention (CSI) on cognitive 
changes with a structured health education program 
(HEP) conducted with the same duration and frequency. 
Using an active comparator instead of a non-
interventional control allows for the evaluation of 
potential superiority and non-inferiority of CSI against 
HEP. If effective, CSI could be scaled-up for 
communities or populations in countries with existing 
resources and a cultural interest in choral music. The 
primary outcome was the change in cognitive function 
during intervention period. We also measured 
secondary biological outcome variables, including brain 
magnetic resonance imaging (MRI) metrics, blood 
markers of immunosenescence and peripheral markers 






 August 2015 and 23
rd
 October 2015, 197 
people were screened for eligibility assessment, 104 were 
excluded and 93 were randomized: 47 to the CSI arm and 
46 to the HEP arm. Follow-up assessments at 12 and 24 
months were completed for a total of 89 and 91 
participants respectively (Figure 1). There were no harms 
or unintended events in either CSI or HEP groups during 
the two-year intervention period. Baseline characteristics 
of randomized participants are shown in Table 1; a T-test 
was conducted and the difference in all variables (i.e. 
age, education, Composite Cognitive Test Score (CCTS), 
Singapore Modified Mini-Mental State Examination 
(SM-MMSE) and Geriatric Depression Scale (GDS)) 
were not statistically significant. Hence, both CSI and 
HEP groups were comparable.  
 
The mean CCTS of participants in the CSI and HEP 
groups increased 0.1 and 0.02 respectively at 12 
months. At the end of 24 months, mean CCTS increased 
0.05 for participants in the CSI arm while the score of 
participants in the HEP arm decreased 0.1. The 
difference in absolute changes of CCTS (point estimate 
0.15, 95% confidence interval 0.01 to 0.3) was 
statistically significant at 24 months at p<0.05. Figure 2 
shows the raw data for absolute changes of CCTS. The 
differences narrowed (point estimate 0.12, 95% 
confidence interval -0.02 to 0.26, p=0.09) when the 
models were adjusted for baseline CCTS; the adjusted 
mean value of absolute change of CCTS for CSI and 
HEP groups was 0.036 and -0.083 respectively at 24 
months (Table 2).   
 
There were no significant between-group differences on 
percentage changes of CCTS at 12 months and 24 
months (data not shown). We also did not find a 
statistically significant main effect of treatment type 
(p=0.37) and the interaction term time* allocation 
(p=0.22) from a Linear Mixed-effects (LME) model 
that consisted of intercept, fixed effects from group 
allocation, time, group*time and random intercepts and 
random slopes for each of the participants. Similar 
results from LME models were found when we 
excluded the interaction term and added age, gender and 
education as fixed effects (Supplementary Figure 2, 
Supplementary Data Additional Tables and Figures).  
 
There were no significant effects of the CSI on any of the 
brain metrics. Effect sizes were small for most metrics, 
with only grey matter (GM) volume, white matter (WM) 
fractional anisotropy (FA) and WM mean diffusivity 
(MD) showing slightly larger effect sizes of between 0.22 
and 0.26 (Figure 3, Table 3). As expected, there was a 
significant main effect of time in the LME model on most 
of brain metrics with significant changes in total brain, 
GM, WM, ventricular and hippocampal volumes, as well 
as MD for GM and WM (Figure 3, Table 3 and 
Supplementary Figure 3, Supplementary Data Additional 
Tables and Figures). The age of the participants at 
baseline was also significantly associated with MD, 
ventricular and hippocampal volume. While gender had a 
significant effect on most volumetric measures derived 
from the T1-weighted scan, there were no significant 
gender effects on the FA and MD values derived from 
diffusion tensor imaging. Education had significant 
effects on brain and WM volume.  
 
There were no significant differences between the CSI 
and HEP groups on levels of the oxidative biomarker 
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levels (Supplementary Figure 4, Supplementary Data 
Additional Tables and Figures). No significant differences 
were observed between CSI and HEP groups on markers 
of immunosenescence, including the frequencies of 
hematopoietic stem cells (HSCs), CD4:CD8 ratios, naïve 
and effector memory RA (TEMRA) CD8 T-cells, naïve 
CD4 T-cells and recent thymic emigrants (RTEs), 
senescent T-cells expressing CD57, PD-1 and KLRG1 
(Supplementary Figure 5, Supplementary Data Additional 
Tables and Figures), suggesting that both have a similar 




In this interim analysis of an RCT, we assessed the 
effects of CSI compared with a HEP on cognitive decline 
during a two-year intervention period. We observed an 




Figure 1. Flow chart of participants through trial. 
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Table 1. Baseline demographic and clinical characteristics of randomized participants. 
Characteristics  Health education program (n=46) Choral singing intervention (n=47) 
Mean (SD) age (years) 69.4 (5.3) 71 (5.7) 
Women 37 (80.4) 36 (76.6) 
Education level:   
  No formal education  4 (8.7) 10 (21.3) 
  Primary school and below 29 (63) 25 (53.2) 
  Secondary school and above  13 (28.3) 12 (25.5) 
Mean (SD) education (years) 6.7 (3.7) 6.1 (4.4) 
Marital status:   
  Single 1 (2.2) 2 (4.3) 
  Married  25 (54.3) 26 (55.3) 
  Divorced or separated 3 (6.5) 4 (8.5) 
  Widowed  17 (37) 15 (31.9) 
Living alone 7 (15.2) 7 (14.9) 
Hypertension 20 (43.5) 28 (59.6) 
Diabetes mellitus  11 (23.9) 14 (29.8) 
Heart diseases  2 (4.3) 1 (2.1) 
Mean (SD) CCTS  0.1 (0.75) -0.1 (0.6) 
Mean (SD) SM-MMSE score  28.1 (1.8) 28.2 (1.9) 
Mean (SD) GDS score 1.5 (2.2) 2.5 (3.3) 
 
choral singing group and a decrease in the mean CCTS 
among participants in the health education group. We did 
not find differences on measures of brain aging, oxidative 
damage and immunosenescence. The findings on CCTS 
changes suggest it is possible that choral singing is 
superior to health education in promoting cognitive 
health in older people, but a definitive conclusion cannot 
be drawn given inadequate statistical power and 
inconsistent findings using different analysis approaches. 
Further research should examine the efficacy with larger 
sample sizes, against existing interventions as well as 
empty controls where feasible. 
 
It is important to note that there was a between-group 
difference on CCTS at baseline, though the difference 
was not statistically significant.  Since participants in 
the CSI group had lower CCTS at baseline, theoretically 




Figure 2. Box plots of raw data for CCTS change from baseline to 12 and 24 Months. Data are median (central line), 
interquartile range (box margins), adjacent values (whiskers), and outlier (dots). 
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Table 2. Estimates of treatment effect on CCTS 
Dependent variable  
12 months 24 months 
Health education Choral singing 
p value 
Health education Choral singing 
p value 
No Mean (SE) No Mean (SE) No Mean (SE) No Mean (SE) 
CCTS change from 
baseline  
44 0.02 (0.03) 45 0.1 (0.04) 0.14 44 -0.1 (0.05) 47 0.05 (0.05) 0.042 
Adjusted for baseline 
CCTS* 
44 0.004 (0.05) 45 0.08 (0.04) 0.18 44 -0.083 (0.05) 47 0.036 (0.05) 0.091* 
*Observed power=0.394. 
 
the outcome variable because of negative correlations 
between baseline and change scores, commonly known 
as the “regression to the mean” phenomenon. When 
baseline CCTS values were controlled for, the between-
group difference on absolute changes in CCTS became 
non-significant, although the effect size was still 
considerable. 
 
Based on this set of data, we are confident in 
concluding that CSI is at least as effective in delaying 
cognitive decline compared to a structured HEP 
targeting known risk factors of dementia such as 
hypertension, obesity, smoking, depression, physical 
inactivity, diabetes, and social isolation [16]. The 
proposed superiority of choral singing over health 
education needs to be further examined and confirmed 
with larger sample sizes. We will be able to draw more 
definitive conclusions on the proposed superiority when 
the sample size is increased by including the planned 
future cycles in the trial and potential extension of the 
study.  
 
Although most of brain markers showed the expected 
decline associated with aging, the group allocation had 
no significant effect on any of the descriptors 
considered here, suggesting that both interventions are 
similarly effective (or ineffective) in preserving brain 




Figure 3. Total Brain, GM, WM and ventricular volume (A), and FA and MD associated with WM of trial participants (B). Thin lines represent 
individual participants whereas thick lines illustrate the average of the choral singing (blue, 37 participants) and health education (red,  
34 participants) groups. Values are normalized to sample average baseline. Error bars represent the standard error of the mean. 
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Table 3. P-values associated with the fixed terms for brain MRI metrics.  
 Intercept Intervention groups Time Age Gender Education Group effect size 
Brain Volume 0.105 0.154 <0.001 0.184 <0.001 0.050 0.013 
Ventricular 
Volume 
0.116 0.976 <0.001 0.036 0.089 0.993 0.169 
GM Volume 0.133 0.549 0.044 0.188 <0.001 0.091 0.253 
WM Volume 0.098 0.063 <0.001 0.085 0.005 0.004 0.106 
Hippocampal 
Volume 
0.002 0.802 0.031 <0.001 0.043 0.847 0.165 
FA WM 0.290 0.181 0.121 0.174 0.974 0.094 0.225 
FA Cortical 0.851 0.984 0.999 0.571 0.170 0.239 0.049 
MD WM <0.001 0.183 0.020 <0.001 0.638 0.561 0.243 
MD Cortical 0.036 0.375 0.001 0.013 0.619 0.188 0.173 
 
longitudinal studies based GM/WM volume and FA 
markers performed in cohorts with similar sample sizes 
have revealed that whole-brain volumetric and diffusion 
markers are sensitive to age decline [17, 18] and group 
intervention [19, 20] in the Chinese population. The 
absence of an association here may suggest that whole-
brain markers are not specific enough to detect potential 
non-overlapping effects of choral singing and health 
education. WM volume showed a trend toward a group 
effect (p=0.06) while FA and MD located at WM had the 
largest effect sizes of all metrics considered. This 
suggests that understanding WM microstructural and 
organizational divergences could be critical for 
characterizing the differential impact that HEP and CSI 
may have in the brain. Further investigation of diffusion 
imaging data using morphometric analysis, Region-Of-
Interest approaches or Tract-based Spatial Statistics 
(TBSS) will be necessary to determine whether the 
potential benefits of choral singing over health education 
are restricted to localized brain regions and specialized 
circuits.  
 
The elevations in biomarkers of oxidative damage have 
long been known to be a pathological factor in 
neurodegeneration and cognitive decline [21, 22]. 
Measuring stable biomarkers of oxidative damage in 
human biofluids can give valuable insights into the sum 
of all damage-driven biological processes and can 
correlate with onset of disease and „unhealthy‟ paradigms 
[23]. However, there were no significant between-group 
differences on peripheral markers of oxidative damage in 
our study. Unfortunately, oxidative stress (and hence 
levels of damage biomarker) are subject to a wide range 
of factors (genetic, environmental, dietary, etc.), which 
may give rise to a higher degree of variability. This may 
be overcome by an increase in sample size. 
 
Empirical evidence has revealed a role of the nervous 
system in regulating immunological responses [24–26]. 
Since music appreciation and production exert 
psychophysiological influence over the autonomous 
nervous system [27], choral singing could theoretically 
modulate immunological imbalances that accumulate 
with age.
  
In single but separate sessions, Kreutz et. al. 
observed increased S-IgA levels in participants 
immediately after singing and listening to choral music 
[28], supporting the idea that choral singing can trigger 
short-term immunological responses. However, in this 
study we did not find favourable effects of CSI on the 
immunosenescence profiles of elderly participants when 
compared with HEP. Although we did not specifically 
study changes in immunoglobulin levels, transient 
immunological modulations are likely to have been 
overlooked because blood collection was organised 
annually as well as during occasions that were isolated 
from choir rehearsals. The observed fluctuations in the 
immunological markers measured in this study were 
minimal. Thus, with reference to reports which suggest 
that immunosenescence is slow but progressive [29, 
30], it is possible that the choral singing intervention 
might have contributed to the preservation of memory 
lymphocyte precursors during the two-year intervention 
period, but its impact may not be immediately 
noticeable.  
 
The strengths of our study include low drop-out rate and 
repeated measurement of cognitive function, brain 
imaging and markers of biological aging.  However, we 
did not include a non-intervention control group so the 
true effects of the CSI on various measures in 
comparison with the natural history of age-related 
changes are unknown. Also, since CSI was provided as 
an integrated package, we are not able to tease out 
relative contributions of the putative cognitive 
enhancing components such as exposure to music, 
making music, and interactions in a group setting. 
Multiple intervention arms (for example: listening to 
music vs. singing alone vs. choral singing) could be 
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considered in future studies, but such designs increase 
costs and the complexity of trial logistics. Another 
obvious limitation is the relatively small sample size, 
providing only 39% power for the observed difference 
on absolute changes of CCTS at 24 months, when 
baseline CCTS was adjusted for.  
 
Our study is the first randomized trial in the world that 
systematically assessed the effects of singing on 
cognitive decline in aging and the potential effects on 
brain imaging, immune system and oxidative damage 
markers. Our findings from the very first RCT on this 
topic suggest that choral singing is a potentially useful 
intervention for the promotion of cognitive health in 
aging.  Choral singing is a safe and enjoyable activity, 
and is likely to be embraced by the community. Policy 
makers may consider promoting choral singing for 
healthy and active aging of seniors in the community. 
This is especially relevant for countries where existing 
resources are available. 
 




This was a single site, parallel-group, randomized active-
controlled trial to assess the efficacy and mechanisms in 
delaying cognitive decline of CSI versus HEP for two 
years. The study was approved by the National 
University of Singapore Institutional Review Board 
(NUS 2508). All participants gave written informed 
consent. Four cycles of the interventions are planned, 
however, only available data from the first cycle are 
reported as a planned interim analysis. Details of the 




We recruited 93 community-living elderly aged 60-84 
years. All participants fulfilled at least one of the 
following criteria: (1) self-reported subjective cognitive 
complaints; or (2) early cognitive impairment defined by 
age- and education-standardized Z-scores in the range of 
-1.5 to 0  for at least five out of ten cognitive test scores 
(details on the tests are provided in the section on 
cognitive outcomes); or (3) having at least two risk 
factors of dementia from: family history of dementia, low 
physical activity, low social engagement, heart disease, 
transient ischemia attack (TIA), diabetes, history of head 
injury, living alone and having depressive symptoms. 
Exclusion criteria were: Clinical Dementia Rating (CDR) 
global score >0, terminal illness, stroke, aphasia, marked 
hearing impairment, or participation in an ongoing 
interventional study. A modified Singapore version of the 
CDR [31] was administered for the assessment of 
dementia severity and calculation of CDR global score. 
Study treatments 
 
The CSI was held weekly for two years at the Yong 
Siew Toh Conservatory of Music, National University of 
Singapore. Each session was one-hour long. Each 
session incorporated the musical, social, and physical 
aspects of choral singing. The focus during the sessions 
was to educate singers to understand the concept of 
sound, the mechanics of the singing voice, and to 
differentiate good from bad singing. Participants were 
then taught more in-depth skills of correct, healthy vocal 
production using good breathing techniques, support and 
listening skills. Later in the program, participants learned 
to sing in different parts. The parts were taught aurally 
and slowly, helping each singer to understand how they 
represent different lines in the musical harmony at any 
point in a two- or more-part musical piece. Professional 
musicians facilitated the sessions in the interventions. 
We also included performances as part of the 
intervention program, the purpose of which was to 
promote motivation and a sense of purpose, pride and 
accomplishment. 
 
The HEP was held weekly for two years at the Training 
and Research Academy at Jurong Point (TaRA@JP), 
Singapore. Each session was one-hour long. The 
sessions consisted of short talks on a health-related 
topic (diabetes, physical activities, healthy eating, 
depression, etc.) followed by group activities that 
required memory work and the acquisition of certain 
skills, but did not involve singing. Physical activity was 
incorporated with 10 minutes of exercise at each 
session. Family physicians, specialist clinicians and 
community nurses facilitated the interventions. 
 
Both CSI and HEP involve cognitively demanding tasks 
such as memorizing new materials. Both CSI and HEP 
were delivered in a group setting as a group activity. 
Hence, there are similarities between the two 
intervention programs on common elements such as 
social interactions, a sense of belonging and the 
building of friendships over time. Both interventions 
may enhance levels of social engagement among 
participants while our observational study supports an 
association between higher social engagement and 
better cognitive health in aging [32].   
 
Data collection  
 
Trained research nurses collected questionnaire data 
through face-to-face interviews at TaRA@JP, 
Singapore. We used the GDS [33, 34] for depressive 
symptoms and the SM-MMSE [35] as a global measure 
of cognitive function. Trained research assistants 
conducted the neuropsychological assessment to collect 
cognitive data at baseline, 12 months, and 24 months. 
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Training to all research staffs was provided by a single 
instructor (LF) to ensure consistency and data quality.  
 
MRI acquisition and processing 
 
MRI data depicting brain structure were collected using 
a 32-channel head coil on a 3T Prisma Siemens MR 
scanner at the Clinical Imaging Research Centre (CIRC) 
at the National University of Singapore (NUS). High-
resolution T1-weighted magnetization-prepared 
gradient-echo images (MPRAGE) were acquired using 
the following parameters: repetition time (TR) = 2300 
ms, echo time (TE) = 2.03 ms, flip angle (FA) = 9 deg, 
1 mm
3
 isotropic voxel resolution and a Field of View 
(FoV) = 256×240 mm
2
 and 176 contiguous slices.  
Cortical and subcortical structures were segmented on 
each MPRAGE image using FreeSurfer v6.0.0 
(http://surfer.nmr.mgh.harvard.edu/). Total brain 
volume, total grey matter (GM) volume, total white 
matter (WM) volume, total ventricular volume, and 
hippocampal volume were extracted from each scan.  
 
Diffusion weighted images (DWI) were acquired using 
an echo planar sequence with 60 gradient directions 
with b-values ranging from 350 to 1600 mm/s, one 
unweighted B0 image, TR = 8500 ms, TE = 96 ms, 2 
mm
3
 voxel resolution, 63 slices, FOV = 192 mm. DWI 
were corrected for B0 field inhomogeneity, Gibbs 
artifacts and eddy-current distortions using MRtrix 3 
and FSL 5·. (http://fsl.fmrib.ox.ac.uk). Fractional 
anisotropy (FA) and mean diffusivity (MD) were 
computed by fitting the diffusion tensor to DWI data 
using FSL FDT. The B0 image was linearly co-
registered to the MPRAGE. The inverse transformation 
was used to map the GM and WM masks into DWI 
space. FA and MD were extracted within both GM and 
WM global and regional masks.   
 
All scans and processed data were quality controlled by 
an experienced researcher (RRG) to reduce the impact 
of head motion and other artifacts. Two participants 
were excluded due to the presence of a brain tumor. 
Two MPRAGE and three DWI scans were removed due 
to motion. Six T1-weighted and nine DWI outliers, 
defined as images with a metric (i.e. volume, FA, and 
MD) exceeding two standard deviations from the mean, 
were also excluded from further analyses. Groups 
remained balanced for age, gender and education after 
the exclusions.  
 
Biomarkers of immunosenescence  
 
Blood specimens was collected in BD Vacutainer® 
CPT™ Mononuclear Cell Preparation Tubes (BD 
Biosciences, USA). The peripheral blood mononuclear 
cell (PBMC) layer was extracted and washed twice with 
Phosphate-buffered saline (PBS) containing 5% fetal 
bovine serum (FBS) (Gibco, USA). PBMCs were 
counted and cryopreserved in 90% FBS with 10% 
dimethyl sulfoxide (DMSO) (MP Biomedicals, USA) 
and stored at -80° C before being transferred to liquid 
nitrogen the following day.  Cryopreserved PBMCs 
were thawed with the aid of cryothaw devices. 
Uncapped cryovials were fitted into cryothaw devices 
(Medax International, USA) that facilitated the transfer 
of cells into 15 ml conical tubes (containing warm 
Roswell Park Memorial Institute medium, RPMI with 
10% FBS) via centrifugation at 400g for 5 minutes. 
Cells were subsequently washed with cold media and 
resuspended for counting using the MACSQuant 
Analyzer 8 (Miltenyi Biotec, Germany). One million 
cells were aliquoted into 96-well plates for staining with 
the antibody cocktail listed in Supplementary Table 2; 
the Thermo Fisher Live/Dead© fixable dye was added 
to the cocktail to distinguish live and dead cells. 
PBMCs were incubated with the mixture in the dark for  
20 minutes at 4° C. Next, cells were washed twice 
before resuspension in Fluorescence activated cell 
sorting (FACS) buffer and analysed on the LSRFortessa 
(BD, USA). Data generated by flow cytometry were 
analysed by the Flowjo© software (Tree Star, Inc., 
USA). Events were gated by forward and side scatter 
followed by subset-specific marker expression to 
identify specific immune subsets. 
 
Biomarkers of oxidative damage 
 
Plasma allantoin and urinary 8-hydroxyguanosine 
(8OHG) and 8-hydroxy-2' -deoxyguanosine (8OHdG) 
were quantified using liquid chromatography mass 
spectrometry (LC-MS/MS) as adapted from Cheah et al 
[36].
 
 Briefly, for allantoin, 10µl of plasma were mixed 
with 100µl methanol containing allantoin-
15
N4, 
overnight at -20° C. Supernatants were dried under a 
stream of N2 gas and resuspended in 100µl deionised 
water. Samples were transferred to silanized sample 
vials for quantification. For 8OHG and 8OHdG, 500µl 





standards were clarified by solid phase extraction 
(Clean Screen FASt; UCT) according to manufacturer‟s 
protocol. Eluted samples were transferred to silanized 
sample vials for quantification. LC-MS/MS was 
performed using an Agilent 1290 LC coupled to a 6460 
triple quadrupole mass spectrometer (Agilent 
Technologies). 5µl of samples were injected onto a 
Hypercarb (5µm, 100x4·6mm; Thermo Scientific) for 
allantoin using gradient elution from 90% of 0·1% 
formic acid (A) to 90% acetonitrile + 0·1% formic acid 
(B) over 8·5 min, or Accucore PFP (2·6µm, 
100x2·1mm; Thermo Scientific) for 8OHG and 8OHdG 
using a gradient elution from 98% A to 95% B over 10 
min. MS was carried out under positive, electrospray 
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ionization in multiple reaction monitoring mode  
with parameters set according to Cheah et al [36].
 
 
Quantification was carried out using a calibration curve 
with no less than 8 standard concentrations and adjusted 
as a ratio of the heavy labelled internal standards. 
 
Cognitive outcomes  
 
We used a standard neuropsychological test battery to 
assess cognitive changes following the interventions. 
The tests in this battery were the Rey Auditory Verbal 
Learning Test (RAVLT), Digit Span, Block Design, 
Color Trails Test (CTT) 1 and 2, Symbol Digit 
Modality Test (SDMT) written and oral version, and 
Boston Naming Test (BNT). Ten test scores were 
produced: (1) RAVLT immediate recall; (2) RAVLT 
delayed recall; (3) Digit Span forward; (4) Digit Span 
backward; (5) Block Design; (6) CTT-1; (7) CTT-2; 
(8) SDMT written; (9) SDMT oral; (10) BNT score.  
The primary outcome of this trial is the change in 
cognitive function measured by the CCTS. The CCTS 
is the average of 10 Z-scores standardized to the 
baseline mean and standard deviation of all trial 
participants (Supplementary Table 1, Supplementary 
Data Additional Tables and Figures), with higher sores 











All the neuropsychological tests have been used in 
previous studies in Singapore [37, 38]. The CCTS was 
negatively correlated with age in a linear manner 
(Supplementary Figure 1, Supplementary Data Additional 
Tables and Figures), indicating that it is a good measure 
of age-related cognitive decline.  
 
Randomization and masking  
 
The randomization list was prepared by an independent 
statistician from the Singapore Clinical Research Institute 
(SCRI) using permuted block randomization and a 1:1 
allocation ratio. The block length was not made known to 
the clinical investigators or site personnel. Opaque, 
sequentially numbered and sealed envelopes were 
prepared by the independent statistician. Trial coordinator 
and trial Principal Investigator (LF) opened the 
randomization envelopes in sequential order to determine 
treatment allocation.  Outcome assessors and laboratory 




We conducted analyses using intention-to-treat 
principles on available data from all participants 
according to their allocation. We produced descriptive 
statistics for various characteristics of the study samples 
at baseline. Between-group comparisons were 
conducted using two-sample t-tests on absolute and per-
centage changes of CCTS from baseline. For any 
positive finding, we further produced adjusted estimates 
controlling for baseline CCTS, in view of the observed 
difference on CCTS at baseline (though not statistically 
significant with formal testing).  We also compared 
between-group differences on CCTS at 12 and 24 
months using two-sample t tests. A LME model was 
conducted to examine the main effect of time and group 
allocation and the interaction of time*allocation on 
CCTS, accounting for repeated measurements on each 
individual.  We then fitted a series of LME models to 
CCTS and each brain metric and biological marker of 
aging. Fixed effects included time, intervention group, 
age, gender and years of education. The participant‟s 
intercept and slope were considered as random effects. 
Interaction terms between the variables were initially 
included in the models, but were discarded in further 
analyses as no statistically significant interactions were 
found in any of the models. Effect sizes were calculated 
as: | ( ) | .Choral HEPx x   All statistical analyses were 
conducted using IBM SPSS version 25.0 and Mat lab. 
 
Sample size  
 
This interim analysis using the first cycle of 
intervention arms allows for the estimation of the 
sample size required to observe a significant change in 
the CCTS primary outcome variable. Assuming a two-
sided type I error rate of 0.05 and statistical power of 
80%, using the estimate of effect size of 0.12 (SD 0.35) 
of the change in CCTS over 24 months gives a sample 




RCT: Randomized Controlled Trials; QOL: Quality of 
Life; CSI: Choral Singing Intervention; HEP: Health 
Education Program; MRI: Magnetic Resonance Imaging; 
CCTS: Composite Cognitive Test Score; SM-MMSE: 
Singapore Modified Mini-Mental State Examination; 
GDS: Geriatric Depression Scale; LME: Linear Mixed-
effects; GM: Grey Matter; WM: White Matter;  
FA: Fractional Anisotropy; MD: Mean Diffusivity;  
HSCs: Hematopoietic Stem Cells; CD: Cluster of 
Differentiation; TEMRA:  Effector Memory RA; RTEs: 
Recent Thymic Emigrants; PD-1: Programmed Cell 
Death Protein 1; KLRG1: Killer Cell Lectin-like 
Receptor G1; TBSS: Tract-based Spatial Statistics; S-
IgA: Secretory Immunoglobulin A; TIA: Transient 
Ischemia Attack; CDR: Clinical Dementia Rating; 
TaRA@JP: Training and Research Academy at Jurong 
Point; LF: Lei Feng; CIRC: Clinical Imaging Research 
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Centre; NUS: National University of Singapore; 
MPRAGE: Magnetization-prepared Gradient-echo; TR: 
Repetition Time; TE: Echo Time; FA: Flip Angle; FoV: 
Field of View; DWI: Diffusion Weighted Images;  
FA: Fractional Anisotropy; MD: Mean Diffusivity; 
RRG: Rafael Romero-Garcia; PBMC: Peripheral  
Blood Mononuclear Cell; PBS: Phosphate-buffered 
Saline; FBS: Fetal Bovine Serum; DMSO: Dimethyl 
Sulfoxide; RPMI: Roswell Park Memorial Institute; 
FACS: Fluorescence Activated Cell Sorting;  
8OHG: 8-hydroxyguanosine; 8OHdG: 8-hydroxy-2' -
deoxyguanosine; LC-MS/MS: liquid Chromatography 
Mass Spectrometry; RAVLT: Rey Auditory Verbal 
Learning Test; CTT: Color Trails Test; SDMT: 
Symbol Digit Modality Test; BNT: Boston Naming 
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MRI acquisition and processing 
 
High-resolution T1-weighted magnetization-prepared 
gradient-echo images (MPRAGE) were acquired using 
the following parameters: repetition time (TR) = 2300 
ms, echo time (TE) = 2·03 ms, flip angle (FA) = 9 deg, 1 
mm
3
 isotropic voxel resolution and a Field of View 
(FoV) = 256×240 mm
2
 and 176 contiguous slices.  
Cortical and subcortical structures were segmented on 
each MPRAGE image using FreeSurfer v6·0·0 
(http://surfer.nmr.mgh.harvard.edu/). Total brain volume, 
total grey matter (GM) volume, total white matter (WM) 
volume, total ventricular volume, and hippocampal 
volume were extracted from each scan.  
 
Diffusion weighted images (DWI) were acquired using 
an echo planar sequence with 60 gradient directions 
with b-values ranging from 350 to 1600 mm/s, one 
unweighted B0 image, TR = 8500 ms, TE = 96 ms, 2 
mm
3
 voxel resolution, 63 slices, FOV = 192 mm. DWI 
were corrected for B0 field inhomogeneity, Gibbs 
artifacts and eddy-current distortions using MRtrix 3 
and FSL 5·0 (http://fsl.fmrib.ox.ac.uk). Fractional 
anisotropy (FA) and mean diffusivity (MD) were 
computed by fitting the diffusion tensor to DWI data 
using FSL FDT. The B0 image was linearly co-
registered to the MPRAGE. The inverse transformation 
was used to map the GM and WM masks into DWI 
space. FA and MD were extracted within both GM and 
WM global and regional masks.   
 
All scans and processed data were quality controlled by 
an experienced researcher to reduce the impact of head 
motion and other artifacts. Two participants were 
excluded due to the presence of a brain tumor. Two 
MPRAGE and three DWI scans were removed due to 
motion. Six T1-weighted and nine DWI outliers, 
defined as images with a metric (i.e. volume, FA, and 
MD) exceeding two standard deviations from the mean, 
were also excluded from further analyses. Groups 
remained balanced for age, gender and education after 
the exclusions.  
 
Biomarkers of immunosenescence  
 
Blood was collected in BD Vacutainer® CPT™ 
Mononuclear Cell Preparation Tubes (BD Biosciences, 
USA). The peripheral blood mononuclear cell (PBMC) 
layer was extracted and washed twice with Phosphate-
buffered saline (PBS) containing 5% fetal bovine  
serum (FBS) (Gibco, USA). PBMCs were counted and 
cryopreserved in 90% FBS with 10% dimethyl 
sulfoxide (DMSO) (MP Biomedicals, USA) and stored 
at -80° C before being transferred to liquid nitrogen the 
following day.  Cryopreserved PBMCs were thawed 
with the aid of cryothaw devices. Uncapped cryovials 
were fitted into cryothaw devices (Medax International, 
USA) that facilitated the transfer of cells into 15 mL 
conical tubes (containing warm Roswell Park Memorial 
Institute medium, RPMI with 10% FBS) via 
centrifugation at 400g for 5 minutes. Cells were 
subsequently washed with cold media and resuspended 
for counting using the MACSQuant Analyzer 8 
(Miltenyi Biotec, Germany). One million cells were 
aliquoted into 96-well plates for staining with the 
antibody cocktail listed in Supplementary Table 2; the 
Thermo Fisher Live/Dead© fixable dye was added to 
the cocktail to distinguish live and dead cells. PBMCs 
were incubated with the mixture in the dark for 20 
minutes at 4° C. Next, cells were washed twice before 
resuspension in Fluorescence activated cell sorting 
(FACS) buffer and analysed on the LSRFortessa (BD, 
USA). Data generated by flow cytometry were analysed 
by the Flowjo© software (Tree Star, Inc., USA). Events 
were gated by forward and side scatter followed by 
subset-specific marker expression to identify specific 
immune subsets. 
 
Biomarkers of oxidative damage 
 
Plasma allantoin and urinary 8-hydroxyguanosine 
(8OHG) and 8-hydroxy-2' -deoxyguanosine (8OHdG) 
were quantified using liquid chromatography mass 
spectrometry (LC-MS/MS) as adapted from Cheah et al. 
Briefly, for allantoin, 10µl of plasma were mixed with 
100µl methanol containing allantoin-
15
N4, overnight at -
20° C. Supernatants were dried under a stream of N2 gas 
and resuspended in 100µl deionised water. Samples 
were transferred to silanized sample vials for 





N2 internal standards 
were clarified by solid phase extraction (Clean Screen 
FASt; UCT) according to manufacturer‟s protocol. 
Eluted samples were transferred to silanized sample 
vials for quantification. LC-MS/MS was performed 
using an Agilent 1290 LC coupled to a 6460 triple 
quadrupole mass spectrometer (Agilent Technologies). 
5µl of samples were injected onto a Hypercarb (5µm, 
100x4·6mm; Thermo Scientific) for allantoin using 
gradient elution from 90% of 0·1% formic acid (A) to 
90% acetonitrile + 0·1% formic acid (B) over 8·5 min, 
or Accucore PFP (2·6µm, 100x2·1mm; Thermo 
Scientific) for 8OHG and 8OHdG using a gradient 
elution from 98% A to 95% B over 10 min. MS was 
carried out under positive, electrospray ionization in 
multiple reaction monitoring mode with parameters set 
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according to Cheah et al. Quantification was carried out 
using a calibration curve with no less than 8 standard 
concentrations and adjusted as a ratio of the heavy 
labelled internal standards. 
  
 










Supplementary Figure 2. CCTS of 47 CSI and 44 HEP participants across time. Thin lines represent individual participants whereas 
thick lines illustrate the average of the choral singing (blue) and health education (red) groups. Values are normalized to sample average 
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Supplementary Figure 3. Additional brain MRI metrics of each participant across time. Thin lines represent individual participants 
whereas thick lines illustrate the average of the Choral (blue) and HEP (red) groups. Values are normalized to each individual baseline. Error 
bars represent the standard error of the mean.  
 
 
Supplementary Figure 4. Markers of oxidative stress for each participant across time. Thin lines represent individual participants 
whereas thick lines illustrate the average values of the choral singing (blue) and health education (red) groups. Values are normalized to 
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Supplementary Figure 5. Frequency of immune subsets for monitoring immunosenescence of 26 CSI and 32 HEP participants 
across time. Hematopoietic stem cells (HSC), CD4:CD8 ratios, naïve and TEMRA CD8 T-cells, Naïve CD4 T-cells, CD4 Recent Thymic Emigrants 
(RTEs), and T-cells expressing exhaustion and senescence markers (CD57, PD1, KLRG1) are shown. Thin lines represent individual participants 
whereas thick lines illustrate the average values of the Choral (blue) and HEP (red) groups. Values are normalized to the population mean. 
Error bars represent the standard error of the mean. 
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Supplementary Tables 
 
Supplementary Table 1. Descriptive statistics of the 10 cognitive test scores at baseline. 
Test score N Minimum Maximum Mean SD 
RAVLT immediate recall 93 23 71 46.63 10.632 
RAVLT delayed recall 93 0 15 9.98 3.043 
Digit Span forward 93 5 16 10.65 2.636 
Digit Span backward 93 2 14 6.06 2.151 
Block Design 93 3 54 27.58 9.846 
CTT 1 93 33 214 69.01 29.991 
CTT 2 93 63 315 134.05 47.183 
SDMT written 93 6 59 31.97 11.871 
SDMT oral 93 4 67 39.13 13.431 
BNT 93 10 30 22.10 5.351 
 
 
Supplementary Table 2. List of antibodies used in T-cell phenotyping panel. 
Antibody Fluorochrome Clone Company Cat 
CD3 BV570 UCHT1 Biolegend 300436 
CD4 A700 OKT4 Biolegend 317426 
CD8 BV650 RPA-T8 BD 563821 
CD127 APC A019D5 Biolegend 351316 
CD25 PE/Cy7 M-A251 Biolegend 356108 
CD27 APC/Cy7 M-T271 Biolegend 356424 
CD45RO BV785 UCHL1 Biolegend 304234 
CD31 BV605 WM59 Biolegend 303122 
CD57 PerCP/Cy5.5 HNK-1 Biolegend 359622 
KLRG1 PE-Vio615 REA261 Miltenyi Biotec 130-108-366 
PD1 BV421 MIH4 BD 564323 
CD95 PE/Cy5 DX2 eBioscience 15-0959-42 
CD34 PE 563 BD 550761 
Vd1 FITC REA173 Miltenyi Biotec 130-100-532 
L/D Aqua 
 
Life Tech L34966 
 
